Literature DB >> 8944557

Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

V Savarino1, G S Mela, P Zentilin, M R Mele, L Lapertosa, R Patetta, E Dallorto, A Vassallo, C Mansi, S Vigneri, G Celle.   

Abstract

BACKGROUND: The presence of gastric metaplasia allows helicobacter pylori to colonise the duodenum and this condition is thought to be acquired as a response to acid hypersecretion. This functional disorder, however, is present only in a subgroup of duodenal ulcer patients and, in addition, surface gastric metaplasia has been frequently found in the proximal duodenum of normal subjects and patients with non-ulcer dyspepsia, who cannot be certainly considered as acid hypersecretors. AIMS: To clarify the role of acid in inducing gastric type epithelium in the duodenum. This study aimed at assessing whether the pattern of circadian gastric acidity differs between H pylori positive duodenal ulcer patients with and without duodenal gastric metaplasia. PATIENTS: Seventy one patients with duodenal ulcer confirmed by endoscopy and who were found to be positive for H pylori infection by histology on antrum biopsy specimens were enrolled into this study.
METHODS: Gastric type epithelium in the duodenum was found in 49 of 71 ulcer patients (69%). Continuous 24 hour gastric pH metry was performed in 50 healthy subjects and in the two subgroups of duodenal ulcer patients with and without gastric metaplasia in the duodenum. Gastric acidity was calculated for 24 hours (1700-1659), night (2000-0759) and day-time (0800-1959).
RESULTS: Ulcer patients without gastric metaplasia showed a significantly higher gastric acidity (p < 0.001) than controls for every time interval considered, while the ulcer subgroup with gastric metaplasia was more acid than healthy subjects (p < 0.001) during the whole 24 hour period and the daytime. There was no difference between the two subgroups of duodenal ulcer patients with and without gastric metaplasia during the various time segments analysed.
CONCLUSION: The findings confirm that the circadian gastric acidity of duodenal ulcer patients is higher than that of controls. As there is no difference in gastric pH between duodenal ulcer patients with and without gastric metaplasia, gastric hyperacidity is not specific to patients with duodenal gastric metaplasia. It is probable that this histological change is a non-specific response to mucosal injury resulting from various factors and not exclusively to acid.

Entities:  

Mesh:

Year:  1996        PMID: 8944557      PMCID: PMC1383261          DOI: 10.1136/gut.39.4.508

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  EXPERMENTAL PRODUCTION OF GASTRIC EPITHELIUM IN THE DUODENUM.

Authors:  J RHODES
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  The relationship between basal and maximum acid output in normal subjects and patients with duodenal ulcer.

Authors:  J H BARON
Journal:  Clin Sci       Date:  1963-06       Impact factor: 6.124

3.  Campylobacter pylori and acid secretion.

Authors:  S Wagner; A Schüler; M Gebel; J Freise; F W Schmidt
Journal:  Lancet       Date:  1989-09-02       Impact factor: 79.321

4.  Chronic nonspecific duodenitis. A multiple biopsy study of the duodenal bulb in health and disease.

Authors:  J Kreuning; A M vd Wal; G Kuiper; J Lindeman
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Duodenal bulb acidity in patients with duodenal ulcer.

Authors:  F Bendtsen; B Rosenkilde-Gram; U Tage-Jensen; L Ovesen; S J Rune
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

6.  Helicobacter pylori infection and gastric metaplasia in the duodenum in China.

Authors:  H Yang; M F Dixon; J Zuo; F Fong; D Zhou; I Corthésy; A Blum
Journal:  J Clin Gastroenterol       Date:  1995-03       Impact factor: 3.062

7.  Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer.

Authors:  S Wagner; U Gladziwa; K Haruma; M Varrentrapp; M Gebel
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

8.  Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease.

Authors:  K A Jönsson; M Ström; G Bodemar; K Norrby
Journal:  Scand J Gastroenterol       Date:  1988-05       Impact factor: 2.423

9.  Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis.

Authors:  J Carrick; A Lee; S Hazell; M Ralston; G Daskalopoulos
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

10.  Gastric metaplasia and Helicobacter pylori infection.

Authors:  L A Noach; T M Rolf; N B Bosma; M P Schwartz; J Oosting; E A Rauws; G N Tytgat
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  4 in total

1.  [1997 gastroenterology update--I].

Authors:  W Fischbach; S S Gro; J Schölmerich; C Ell; P Layer; W E Fleig; H Zirngibl
Journal:  Med Klin (Munich)       Date:  1998-02-15

2.  Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; G Bisso; M Pivari; C Mansi; L Tessieri; G Lapertosa; P Ceppa; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

3.  H. pylori infection induced BMAL1 expression and rhythm disorder aggravate gastric inflammation.

Authors:  Tongyu Li; Wei Shao; Shuyan Li; Lin Ma; Lixin Zheng; Wenjing Shang; Xiaxia Jia; Pengpeng Sun; Xiuming Liang; Jihui Jia
Journal:  EBioMedicine       Date:  2018-11-27       Impact factor: 8.143

4.  Robust circadian rhythms in organoid cultures from PERIOD2::LUCIFERASE mouse small intestine.

Authors:  Sean R Moore; Jill Pruszka; Jefferson Vallance; Eitaro Aihara; Toru Matsuura; Marshall H Montrose; Noah F Shroyer; Christian I Hong
Journal:  Dis Model Mech       Date:  2014-07-04       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.